• Dearden, C.E., Matutes, E., Cazin, B., Tjønnfjord, G.E., Parreira, A., Nomdedeu, B., Leoni, P., Clark, F.J., Radia, D., Rassam, S.M., Roques, T., Ketterer, N., Brito-Babapulle, V., Dyer, M.J. & Catovsky, D. (2001) High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood, 98, 17211726.
  • Dungarwalla, M., Matutes, E. & Dearden, C.E. (2008) Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper. European Journal of Haematology, 80, 469476.
  • Keating, M.J., Cazin, B., Coutré, S., Birhiray, R., Kovacsovics, T., Langer, W., Leber, B., Maughan, T., Rai, K., Tjønnfjord, G., Bekradda, M., Itzhaki, M. & Hérait, P. (2002) Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed. Journal of Clinical Oncology, 20, 205213.
  • Matutes, E., Brito-Babapulle, V., Swansbury, J., Ellis, J., Morilla, R., Dearden, C., Sempere, A. & Catovsky, D. (1991) Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood, 78, 32693274.
  • Mercieca, J., Matutes, E., Dearden, C., MacLennan, K. & Catovsky, D. (1994) The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype. Journal of Clinical Oncology, 12, 25882593.
  • Robak, T. & Robak, P. (2007) Current treatment options in prolymphocytic leukemia. Medical Science Monitor, 13, RA69RA80.